The Cohort Study of Uveitis Patients

Study Overview
=================
Brief Summary
-----------------
This study intends to explore the epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of uveitis. This is a cohort study. The outcome of the study is the activity of inflammation and visual prognosis. The purpose of this study is to determine the optimal diagnosis and treatment scheme for uveitis patients based on real-world data.

Official Title
-----------------
The Cohort Study of Uveitis Patients Based on Real-world Data

Conditions
-----------------
Uveitis

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: The diagnosis is uveitis; The agreement of enrolling this study; Exclusion Criteria: Uveitis during the first month after any intraocular surgery; <18 years; pregnant and lactating women; other conditions are unsuitable for participation in this study by the investigator such as mental abnormalities.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 90 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Noninfectious uveitis<br> | |
| Infectious uveitis<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 12 months post-treatment | 
| The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions | inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography | 12 months post-treatment | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Best corrected visual acuity | Best corrected visual acuity | 1 month post-treatment | 
| Best corrected visual acuity | Best corrected visual acuity | 3 months post-treatment | 
| Best corrected visual acuity | Best corrected visual acuity | 6 months post-treatment | 
| Best corrected visual acuity | Best corrected visual acuity | 12 months post-treatment | 
| Best corrected visual acuity | Best corrected visual acuity | 24 months post-treatment | 
| Best corrected visual acuity | Best corrected visual acuity | 36 months post-treatment | 
| The number of intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 1 month post-treatment | 
| The number of intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 3 months post-treatment | 
| The number of intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 6 months post-treatment | 
| The number of Intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 12 months post-treatment | 
| The number of Intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 24 months post-treatment | 
| The number of Intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 36 months post-treatment | 
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 1 month post-treatment | 
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 3 months post-treatment | 
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 6 months post-treatment | 
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 12 months post-treatment | 
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 24 months post-treatment | 
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 36 months post-treatment | 
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 1 month post-treatment | 
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 3 months post-treatment | 
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 6 months post-treatment | 
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 24 months post-treatment | 
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 36 months post-treatment | 
| The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions | inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography | 3 months post-treatment | 
| The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions | inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography | 6 months post-treatment | 
| The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions | inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography | 24 months post-treatment | 
| The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions | inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography | 36 months post-treatment |